OpenAlex
PricingAboutJobs
Log inGet started
Work

A phase I and pharmacokinetic study of elisidepsin (PM02734) in patients with advanced solid tumors

HTML

Year: 2012
Type: article
Study design: Clinical Trial
Source: Cancer Chemotherapy and Pharmacology
DOI: 10.1007/s00280-012-1951-6
Authors: R. Salazar, R. J. Jones, A. Oaknin, D. Crawford, C. Cuadra, C. Hopkins, M. Gil, C. Coronado, A. Soto-Matos, M. Cullell-Young, J. L. Iglesias Dios, T. R. J. Evans
Institutions: Institut Català d'Oncologia, Beatson West of Scotland Cancer Centre, University of Glasgow, PharmaMar (Spain)
Language: English

Topic: Histone Deacetylase Inhibitors Research
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: topoisomerase I inhibitor, advanced solid tumors, refractory cancer, maximum tolerated dose, dose-limiting toxicity, pharmacokinetics, transaminase elevation, anticancer activity, esophageal adenocarcinoma, fixed-dose regimen
SDG: Good health and well-being

Open Access status: closed

Funder: Cancer Research UK
Award: G6591838237
OpenAlex ID: W2015755263
FWCI: 0.819
Cites: 26
Cited by: 22
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security